EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The association of human apolipoprotein ε4 with dementia, cognition, imaging, and plasma biomarkers of neurodegeneration in a sample of older adults in the Democratic Republic of the Congo

Jean Ikanga, Saranya Sundaram Patel iD, Megan Schwinne, Caterina Alessandra Obenauf, Emmanuel Epenge, Guy Gikelekele, Nathan Tshengele, Immaculee Kavugho, Samuel Mampunza, Lelo Mananga, Charlotte E Teunissen, Julio C Rojas und 7 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Jean Ikanga und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Apolipoprotein E4, Dementia, Cognition. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION This study examined the association between the apolipoprotein E ( APOE ) ε4 allele and cognitive performance, neuroimaging, and plasma biomarkers in Congolese older adults in the Democratic Republic of the Congo (DRC). METHODS Eighty‐four participants (39 healthy controls [HCs], 45 with suspected dementia), aged 73.0 years on average, were assessed using the African Neuropsychology Battery, magnetic resonance imaging, and blood‐based biomarkers. Regression models adjusted for age, sex, and education evaluated APOE ’s impact. RESULTS APOE ε4 was more prevalent in dementia cases than in HCs. Overall, APOE ε4 status significantly affected naming and memory scores, mesial temporal and entorhinal cortex atrophy scores, and glial fibrillary acidic protein concentration levels. In HCs, it showed no significant impact on cognitive or neuroimaging tests, except for neurofilament light chain concentration levels. Among dementia participants, APOE ε4 status influenced only naming and memory scores. DISCUSSION APOE ε4 carriers in this DRC cohort showed greater cognitive decline and neurodegeneration, highlighting its significant impact in African populations. Highlights Apolipoprotein E ( APOE ) ε4 was more frequent in dementia cases than in healthy controls in a Democratic Republic of the Congo cohort. APOE ε4 carriers showed greater cognitive decline, especially in memory and visuospatial skills. Neuroimaging findings revealed increased hippocampal atrophy and cortical thinning in carriers. Plasma biomarkers in dementia showed higher amyloid beta 40, phosphorylated tau181, neurofilament light chain, and tumor necrosis factor alpha levels. Findings underscore APOE ε4's impact on neurodegeneration in African populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein E4DementiaCognitionHumansMaleFemaleAgedBiomarkersDemocratic Republic of the CongoMagnetic Resonance ImagingNeuropsychological TestsAtrophyAged, 80 and overNeuroimagingtau Proteins

Stichwörter der Autor:innen

Congoapolipoprotein Ebiomarkerscognitiondementia

Substanzen

Apolipoprotein E4Biomarkerstau Proteins

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • School of Medicine, Kinshasa, Department of Psychiatry, University of Kinshasa and Catholic University of Congo, Kinshasa, Democratic Republic of Congo.
  • OneRehab, Dallas, Texas, USA.
  • Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Department of Neurology, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
  • Memory Clinic of Kinshasa, Kinshasa, Democratic Republic of Congo.

ORCID-Profile: Saranya Sundaram Patel

Förderung

  • NIA NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Ikanga, J., Patel, S. S., Schwinne, M., Obenauf, C. A., Epenge, E., Gikelekele, G., Tshengele, N., Kavugho, I., Mampunza, S., Mananga, L., Teunissen, C. E., Rojas, J. C., Chan, B., Lago, A. L., Boxer, A. L., Jeromin, A., Omba, E., Gross, A. L., & Alonso, A. (2025). The association of human apolipoprotein ε4 with dementia, cognition, imaging, and plasma biomarkers of neurodegeneration in a sample of older adults in the Democratic Republic of the Congo. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70735

Vancouver

Ikanga J, Patel SS, Schwinne M, Obenauf CA, Epenge E, Gikelekele G, et al. The association of human apolipoprotein ε4 with dementia, cognition, imaging, and plasma biomarkers of neurodegeneration in a sample of older adults in the Democratic Republic of the Congo. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70735

BibTeX
@article{Ikanga2025,
  author = {Ikanga, Jean and Patel, Saranya Sundaram and Schwinne, Megan and Obenauf, Caterina Alessandra and Epenge, Emmanuel and Gikelekele, Guy and Tshengele, Nathan and Kavugho, Immaculee and Mampunza, Samuel and Mananga, Lelo and Teunissen, Charlotte E and Rojas, Julio C and Chan, Brandon and Lago, Argentina Lario and Boxer, Adam L and Jeromin, Andreas and Omba, Emile and Gross, Alden L and Alonso, Alvaro},
  title = {The association of human apolipoprotein ε4 with dementia, cognition, imaging, and plasma biomarkers of neurodegeneration in a sample of older adults in the Democratic Republic of the Congo},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70735}
}
Kostenlos starten →